Hydroxysteroid (17beta) dehydrogenase type 1 (HSD17B1) is an enzyme that converts estrone to estradiol, while adenomyosis is an estrogen-dependent disease with poorly understood pathophysiology. In the present study, we show that mice unive…
This invention relates to benzo (4, 5) thieno (2, 3-d) pyrimidin-4-one compounds, their 5,6-dihydro and 5, 6, 7, 8-tetrahydro derivatives and their use for the treatment of a steroid hormone dependent disease or disorder, preferably for a s…
This invention relates to benzo (4, 5) thieno (2, 3-d) pyrimidin-4-one compounds, their 5,6-dihydro and 5, 6, 7, 8-tetrahydro derivatives and their use for the treatment of a steroid hormone dependent disease or disorder, preferably for a s…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
This invention relates to benzo (4, 5) thieno (2, 3-d) pyrimidin-4-one compounds, their 5,6-dihydro and 5, 6, 7, 8-tetrahydro derivatives and their use for the treatment of a steroid hormone dependent disease or disorder, preferably for a s…
3,15-substituted estrone compounds which act as inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), salts thereof, pharmaceutical preparations containing such compounds, processes for preparing such compounds, and therap…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…